Furthermore, tobacco smoke, inhaled drugs and sulforaphane can modulate MRP1 activity and/or abundance in distal lung epithelial cells in vitro, implying the transporter could be a novel therapeutic target of COPD. Here, ABCC1 is linked to chronic obstructive pulmonary disease.